Last reviewed: June 21, 2026
Last updated: June 21, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic®, works by slowing stomach emptying and signaling fullness to your brain—mechanisms that typically reduce appetite within days of starting treatment. However, the right starting dose depends on your individual biology, not just your weight. PlexusDx helps patients identify personalized dosing strategies using genetic insights that predict how your body responds to GLP-1 therapy.
Understanding Starting Doses for Semaglutide Therapy
Most semaglutide weight loss programs begin at 0.25 mg once weekly, a dose designed to minimize nausea while your digestive system adjusts to the medication. This introductory phase typically lasts 4 weeks before progression is considered. The purpose of a low starting dose is dual: it allows your body to build tolerance to GLP-1 receptor activation, and it gives you and your healthcare provider time to assess how well you tolerate the medication.
Your dose may need to increase based on tolerance and weight loss response, but your monthly cost with PlexusDx remains flat regardless of advancement. This pricing structure removes the financial barrier to dose optimization—patients can focus on finding their therapeutic dose without worry about escalating expenses. PlexusDx compounded semaglutide injections start at $149 per month across all commitment tiers.
Why Genetic Testing Improves Your Starting Strategy
Your genes influence how efficiently your body processes GLP-1 signaling and how your metabolism responds to appetite suppression. The Precision Peptide Genetic Test measures 14 metabolic pathways and 49 peptides linked to weight regulation, including variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) that predict individual treatment response. These genetic markers do not determine your outcome, but they provide your provider with valuable context for predicting whether you may benefit from higher doses, faster titration, or combination therapy.
PlexusDx patients who add the Precision Peptide Genetic Test ($99 after their first month of treatment) gain a detailed map of their peptide pathway strengths and weaknesses. This information helps your clinician anticipate which dose levels may deliver the most effective appetite suppression without unnecessary side effects, creating a truly personalized treatment roadmap from week one.
Dose Progression Timeline and Expectations
The standard semaglutide titration schedule increases your dose by 0.25 mg every 4 weeks—moving from 0.25 mg to 0.5 mg to 1.0 mg and potentially reaching 2.4 mg as your target maintenance dose. However, progression timelines vary based on individual tolerance, weight loss momentum, and whether you experience gastrointestinal side effects. Some patients reach their therapeutic dose in 8 weeks, while others benefit from a slower 12-week or 16-week progression that allows full adaptation at each level.
PlexusDx licensed 503A compounding pharmacies prepare semaglutide at any dose your provider prescribes, allowing flexible titration schedules tailored to your body's response. Your monthly cost remains consistent whether you are at 0.25 mg or 2.4 mg, removing the incentive to stay at suboptimal doses for financial reasons. This aligns PlexusDx pricing with clinical best practices: advancing to the dose that works best for you.
Combining Genetic Insights with Compounded Options
PlexusDx offers multiple formulations—injections and oral tablets—so you can choose the delivery method that fits your lifestyle while benefiting from genetic-informed dosing. Compounded semaglutide injections begin at $149 monthly, while oral semaglutide starts at $249 monthly. Patients interested in dual-compound therapy, such as GLP-Squared (semaglutide plus tirzepatide), have options starting at $249 monthly for the injection version and $369 monthly for the oral form.
When you add the Precision Peptide Genetic Test to your first month of treatment, your provider receives actionable data about your MC4R pathway status (rs17782313), your insulin sensitivity genetic predispositions, and your hormone regulation potential. This intelligence informs whether you might respond better to monotherapy, a combination protocol, or an accelerated dose schedule. All PlexusDx medications are compounded at licensed 503A pharmacies, are available in all 50 states without insurance, and are eligible for HSA and FSA accounts.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is a safe starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected once weekly, maintained for 4 weeks before increasing. This dose is low enough to allow your body to adjust while still engaging GLP-1 receptors that signal satiety. Your healthcare provider may recommend a different starting point based on your medical history, medications, and genetic profile from the Precision Peptide Genetic Test.
How does the Precision Peptide Genetic Test help choose my starting dose?
The test analyzes 150+ genetic insights across 14 metabolic pathways, including GLP1R and GIPR variants that predict how strongly your body responds to GLP-1 signaling. Patients with certain genetic profiles may benefit from faster dose progression or earlier advancement to combination therapy, allowing PlexusDx providers to customize your starting strategy rather than using a one-size-fits-all approach.
Will my PlexusDx cost increase as my dose goes up?
No. PlexusDx compounded semaglutide injections cost $149 monthly regardless of whether you take 0.25 mg or 2.4 mg, and oral semaglutide costs $249 monthly across all doses. This flat-rate pricing ensures your financial commitment stays constant as your provider optimizes your therapeutic dose.
What side effects should I expect when starting semaglutide?
Nausea, mild vomiting, and reduced appetite are common in the first 2-3 weeks and often decrease as your body adapts. Constipation and mild dizziness occur less frequently. Most side effects resolve within days to weeks, and a slower dose progression can minimize their severity. If side effects persist beyond 4 weeks, contact your PlexusDx provider immediately.
How does my genetic profile from the Precision Peptide Test affect my dose plan?
Variants in your GLP1R, GIPR, FTO, and MC4R genes suggest how efficiently you regulate appetite through different peptide pathways. Certain genetic patterns predict stronger responses at standard doses, while others suggest benefit from higher target doses or combination therapies. PlexusDx clinicians use this data to build a personalized dose roadmap instead of guessing your optimal therapy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Who Should Not Use Ozempic for Weight Loss?
Is Wegovy Indicated for Weight Loss? Exploring Its Role and Effectiveness